NCBiotech News

North Carolina's Research Triangle, birthplace and global centerpiece of the huge contract research enterprise, is losing a homegrown headquarters with a $12 billion buyout of PRA Health Sciences by Ireland-based ICON plc.

Pittsboro-based startup Propella Therapeutics is teaming up with the National Cancer Institute (NCI) to evaluate its new treatment for metastatic prostate cancer.

Sam Taylor, a founder and long-time president of the state's life sciences trade association, NCBIO, has died of pancreatic cancer.

[Editor's note from Tracey du Laney, Ph.D., the North Carolina Biotechnology Center’s senior director of Science and Technology Development, who oversees this grant: This line of research exemplifies what a Flash Grant is all about. The nanosphere  technology that Dr. Brown’s team is developing addresses a large patient population with unmet needs in a new way. It could lead to new therapeutics to treat disseminated intravascular coagulation (DIC). DIC results not just from sepsis and cancer, but also has emerged as a life-threatening condition with COVID-19.

Advanced Chemotherapy Technologies, a Raleigh medical device startup developing a way to improve the treatment of pancreatic cancer, has added $2.5 million in funding to support clinical testing of its technology.

Durham-based regenerative medicine company Humacyte is going public in a novel deal that will give it a market capitalization of $1.1 billion.

A drug being developed by Cary-based Rescindo Therapeutics for treating a rare developmental disorder in children has received two special designations from the FDA.

Life sciences manufacturing companies in North Carolina expanded their collective workforce by more than 11%.in 2020, in sharp contrast to the global economic downturn wrought by the COVID-19 pandemic.

RTP's G1 Therapeutics has received FDA approval of its first drug, for protecting bone marrow from chemotherapy damage.

Veteran pharmaceutical company executive Machelle Sanders, a North Carolina native and former board member of the North Carolina Biotechnology Center, was named Secretary of the Department of Commerce today by Governor Roy Cooper.

NC IDEA is welcoming entrepreneurs statewide to submit MICRO and SEED Grant applications until March 1.

Medical device maker Bioventus is the latest North Carolina life sciences firm joining the public markets, raising $104 million from its initial public offering.

A $1.5 million gift from the North Carolina GlaxoSmithKline Foundation will help community college students pursue science, technology, engineering and math (STEM) degrees at North Carolina Agricultural and Technical State University in Greensboro.

Durham's Spencer Health Solutions is striking up alliances with pharma companies, using its smart medication dispensing technology to monitor how patients take their drugs at home while also providing the drug makers insight about how the medicines in clinical testing are working.

Durham-based Heat Biologics reported positive interim results from a phase 2 clinical trial of its therapy to treat advanced non-small cell lung cancer.